Literature DB >> 22777641

Beyond "safe sex"--can we fight adolescent pelvic inflammatory disease?

Bahaa Abu Raya1, Ellen Bamberger, Nogah C Kerem, Aharon Kessel, Isaac Srugo.   

Abstract

Pelvic inflammatory disease (PID) is a common disorder affecting sexually active adolescents. The Centers for Disease Control and Prevention (CDC) and European CDC report Chlamydia trachomatis as the most common sexually transmitted infection and one of the main etiological agents causing PID. C. trachomatis' and PID's high prevalence may be attributed to multiple factors including high-risk sexual behaviors, sensitive laboratory diagnostics (polymerase chain reaction), and the introduction of chlamydia screening programs. The pathogenesis of C. trachomatis infection is complex with recent data highlighting the role of toll-like receptor 2 and four in the mediation of the inflammatory cascade. The authors review the etiology of the disease, explore its pathogenesis, and discuss a variety of strategies that may be implemented to reduce the prevalence of C. trachomatis including: (a) behavioral risk reduction, (b) effective screening of asymptomatic females, (c) targeted male screening, (d) implementation of a sensitive, rapid, self-administered point-of-care testing, and (e) development of an effective vaccine.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22777641     DOI: 10.1007/s00431-012-1786-5

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  63 in total

Review 1.  Pelvic inflammatory disease in adolescents.

Authors:  M Rosanna Gray-Swain; Jeffrey F Peipert
Journal:  Curr Opin Obstet Gynecol       Date:  2006-10       Impact factor: 1.927

2.  Mycoplasma genitalium: should we treat and how?

Authors:  Lisa E Manhart; Jennifer M Broad; Matthew R Golden
Journal:  Clin Infect Dis       Date:  2011-12       Impact factor: 9.079

3.  Variants in toll-like receptor 1 and 4 genes are associated with Chlamydia trachomatis among women with pelvic inflammatory disease.

Authors:  Brandie D Taylor; Toni Darville; Robert E Ferrell; Candace M Kammerer; Roberta B Ness; Catherine L Haggerty
Journal:  J Infect Dis       Date:  2012-01-11       Impact factor: 5.226

4.  Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial.

Authors:  Roberta B Ness; David E Soper; Robert L Holley; Jeffrey Peipert; Hugh Randall; Richard L Sweet; Steven J Sondheimer; Susan L Hendrix; Antonio Amortegui; Giuliana Trucco; Thomas Songer; Judith R Lave; Sharon L Hillier; Debra C Bass; Sheryl F Kelsey
Journal:  Am J Obstet Gynecol       Date:  2002-05       Impact factor: 8.661

Review 5.  Chlamydial pelvic inflammatory disease.

Authors:  J Paavonen; M Lehtinen
Journal:  Hum Reprod Update       Date:  1996 Nov-Dec       Impact factor: 15.610

6.  Role of T lymphocytes in the pathogenesis of Chlamydia disease.

Authors:  Joseph U Igietseme; Qing He; Kahaliah Joseph; Francis O Eko; Deborah Lyn; Godwin Ananaba; Angela Campbell; Claudiu Bandea; Carolyn M Black
Journal:  J Infect Dis       Date:  2009-09-15       Impact factor: 5.226

7.  Prevalence of sexually transmitted infections among sexually active Jordanian females.

Authors:  Azmi M Mahafzah; Muataz Q Al-Ramahi; Ali M Asa'd; Mohammad S El-Khateeb
Journal:  Sex Transm Dis       Date:  2008-06       Impact factor: 2.830

8.  Protective or pathogenic immune response to genital chlamydial infection in women--a possible role of cytokine secretion profile of cervical mucosal cells.

Authors:  T Agrawal; R Gupta; R Dutta; P Srivastava; A R Bhengraj; S Salhan; Aruna Mittal
Journal:  Clin Immunol       Date:  2008-11-20       Impact factor: 3.969

9.  Mycoplasma genitalium among adolescent women and their partners.

Authors:  Aneesh K Tosh; Barbara Van Der Pol; J Dennis Fortenberry; James A Williams; Barry P Katz; Byron E Batteiger; Donald P Orr
Journal:  J Adolesc Health       Date:  2007-02-15       Impact factor: 5.012

Review 10.  Effectiveness of chlamydia screening: systematic review.

Authors:  Nicola Low; Nicole Bender; Linda Nartey; Aijing Shang; Judith M Stephenson
Journal:  Int J Epidemiol       Date:  2008-12-05       Impact factor: 7.196

View more
  1 in total

1.  RNA Biosignatures in Adolescent Patients in a Pediatric Emergency Department With Pelvic Inflammatory Disease.

Authors:  Fran Balamuth; Zhe Zhang; Eric Rappaport; Katie Hayes; Cynthia Mollen; Kathleen E Sullivan
Journal:  Pediatr Emerg Care       Date:  2015-07       Impact factor: 1.454

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.